에스디바이오센서

137310KOSPI의료용 기기 제조업

51.5 / 100

Reference Date: 2026-07-24

Financial Score15.0 / 40

News Sentiment19.5 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

SD Biosensor, established in 2010, specializes in in-vitro diagnostics, offering products such as STANDARD Q, STANDARD F, and STANDARD E, which are known for high sensitivity and specificity. These products are used for rapid testing of various diseases, including COVID-19, and hold significant market share globally. The in-vitro diagnostics industry plays a crucial role in disease prevention and public health, with stringent regulations in major countries.

Number of Employees

656people

Average Salary

67.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 20.044.0Point

PBR

0.31Industry Average 1.147.0Point

Half of industry avg (excellent)

ROE

-19.49Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

18.81Industry Average 11.650.5Point

1.6x industry avg (risky)

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲4.1% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲14.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -13.0% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 4Neutral 1Negative 0Average Sentiment Score 78

Positive
'국내 최대 M&A' 삼성바이오, 펩타이드 품고 글로벌 CDMO 1위 ...
SD바이오센서의 글로벌 경쟁력 강화를 위한 대규모 인수합병으로 긍정적 영향 예상.
Positive
에스디바이오센서, 결핵 진단 제품으로 글로벌 공공조달 시장 공략
에스디바이오센서의 새로운 결핵 진단 제품이 글로벌 공공조달 시장 진출을 통해 성장 기회를 확대하고 있다.
Positive
에스디바이오센서, ‘스탠다드 엠텐 MTB-RIF/INH’ 글로벌펀드 ...
에스디바이오센서의 새로운 결핵 분자진단 제품이 글로벌펀드의 지원을 받아 시장 경쟁력을 강화할 것으로 기대됩니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (4%, downtrend)

Current 6,050Won52-week high 10,84052-week low 5,820

1-month return3.0Point

1m -0.98% (flat)

Volume trend3.0Point

Volume flat

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral금전대여결정2026-07-10